Cyclica is the partner of choice for data-driven drug discovery.
Cyclica is the partner of choice for data-driven drug discovery. They advance molecules that embrace the complexity of the disease. They decentralize innovation with technology, build novel data-driven pipelines, and fuel cross-organizational collaborations at a molecular level.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 15, 2022 | Grant | $2.40M | 1 |
Bill & Melinda Gates Foundation
|
— | Detail |
| Jun 24, 2020 | Series B | $23M | 4 |
Drive Capital
|
— | Detail |
| Jul 1, 2019 | Series Unknown | — | 1 | — | — | Detail |
| Jul 26, 2017 | Series A | $2.25M | 4 |
GreenSky Capital
|
— | Detail |
| Sep 22, 2016 | Series A | $2.40M | 2 |
GreenSky Capital
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Bill & Melinda Gates Foundation
|
Yes | Grant |
Drive Capital
|
Yes | Series B |
Chiesi Pharmaceuticals
|
— | Series B |
GreenSky Capital
|
— | Series B |
Naheed Kurji
|
— | Series B |
EPIC Capital
|
— | Series A |
Hanhai Studio
|
— | Series A |
|
|
— | Series A |
|
|
— | Series A |
StartUp Health
|
— | Seed |